Investigating serum factors promoting erythrocytic growth of Plasmodium falciparum |
| |
Authors: | Asahi Hiroko Kanazawa Tamotsu Hirayama Nakami Kajihara Yousei |
| |
Affiliation: | Department of Parasitology, National Institute of Infectious Diseases, 23-1 Toyama 1-chome, Shinjuku-ku, Tokyo 162-8640, Japan. asahih@nih.go.jp |
| |
Abstract: | The elucidation of factors inducing the growth of Plasmodium falciparum can provide critical information about the developmental mechanisms of this parasite and open the way to search for novel targets for malaria chemotherapy. The ability of components of a growth-promoting factor derived from bovine serum and various related substances to sustain growth of P. falciparum was characterized. A simple total lipid fraction (GFS-C) containing non-esterified fatty acids (NEFAs) as essential factors was noted to promote the parasite's growth. Various proteins from a variety of animals were tested, indicating the importance not only of GFS-C, but also of specific proteins, such as bovine and human albumin, in the parasite growth. Several combinations of the NEFAs tested sustained low parasite growth. Among various phospholipids and lysophospholipids tested, lysophosphatidylcholine containing C-18 unsaturated fatty acids was found to sustain the complete development of the parasite in the presence of bovine albumin. Several other lysophospholipids can partially support growth of P. falciparum. |
| |
Keywords: | ALB, albumin ANOVA, multifactorial analysis of variance BSAF, NEFA-free ALB from bovine C16:0, hexadecanoic acid C16:1, cis-9-hexadecenoic acid C18:0, octadecanoic acid C18:1, cis-9-octadecenoic acid C18:2, cis,cis-9,12-octadecadienoic acid C18:3, cis,cis,cis-6,9,12-octadecatrienoic acid C20:4, cis-5,8,11,14-eicosatetraenoic acid C20:5, cis-5,8,11,14,17-eicosapentaenoic acid C22:6, cis-4,7,10,13,16,19-docosahexaenoic acid CDKs, cyclin-dependent protein kinases CDPKs, calcium-dependent protein kinases CHOL, cholesterol CRPMI, basal medium DGs, diglycerides FBS, fetal bovine serum GFS, a growth-promoting fraction derived from adult bovine serum GFS-C, a total simple lipid fraction obtained from GFS GFSRPMI, CRPMI containing 10% GFS GFS-WM, a total complex lipid fraction obtained from GFS Hepes, 4-(2-hydroxyethyl)-piperazine ethanesulfonic acid HS, human serum HSRPMI, CRPMI containing 10% HS LPA, lysophosphatidic acid 18:1 LPA, cis-9-oleoyl LPA LPC, lysophosphatidylcholine 12:0 LPC, lauroyl LPC 14:0 LPC, myristoyl LPC 16:0 LPC, palmitoyl LPC 18:0 LPC, stearoyl LPC 18:1 LPC, cis-9-oleoyl LPC 18:2 LPC, cis-9-linoleoyl LPC 18:U LPC, LPC containing primarily C-18 unsaturated fatty acids LPC-brain, LPC from bovine brain LPCRPMI, CRPMI containing 3 mg/ml BSAF and 40 μg/ml 18:U LPC LPE, lysophosphatidyl ethanolamine LPI, lysophosphatidyl inositol LPS, lysophosphatidyl serine Lyso PAF, γ-O-alkyl LPC MAPK, mitogen-activated protein kinase MEK, MAPK/extracellular signal-regulated kinase kinase MGs, monoglycerides NEFA, non-esterified fatty acid OD650, absorbance at 650 nm 8:0 PA, dioctanoyl phosphatidic acid 18:1 PA, cis-9-dioleoyl phosphatidic acid PAF, β-acetyl-γ-O-alkyl PC PC, phosphatidylcholine PE, phosphatidyl ethanolamine PI, phosphatidyl inositol PI-bovine, PI from bovine liver PI-soybean, PI from soybean PKC, protein kinase C PLs, phospholipids pLDH, parasite lactate dehydrogenase PS, phosphatidyl serine PTK, protein tyrosine kinase RBCs, red blood cells SD, standard deviation SM, sphingomyelin S-1-P, sphingosine 1-phosphate SPC, sphingosylphosphorylcholine sphingosine, smallcaps" >d- sphingosine |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|